Current diagnostic methods for prostate cancer (PCa) include serum prostate-specific antigen (PSA), transrectal ultrasound (TRUS), digital rectal examination (DRE), magnetic resonance imaging (MRI), and tissue biopsy. The gene discussed is KLK3; the disease is Familial prostate cancer.